estradiol 1 MG / norethindrone acetate 0.5 MG / relugolix 40 MG Oral Tablet [Myfembree]
RxNorm concept 2556800, branded drug (sbd). Prescribable name: Myfembree (relugolix 40 MG / estradiol 1 MG / norethindrone acetate 0.5 MG) Oral Tablet.
- RxCUI
- 2556800
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2556800 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Myfembree (relugolix 40 MG / estradiol 1 MG / norethindrone acetate 0.5 MG) Oral Tablet
Related concepts
- estradiol 1 MG (SCDC, consists of)
- norethindrone acetate 0.5 MG (SCDC, consists of)
- relugolix 40 MG (SCDC, consists of)
- estradiol 1 MG / norethindrone acetate 0.5 MG [Myfembree] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Myfembree (BN, has ingredient)
- estradiol 1 MG / norethindrone acetate 0.5 MG / relugolix 40 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2556800 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2556800 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2556800. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.